Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash & Equivalents Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn 175.09%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 175.09%
Sep 30, 2025 57.67%
Jun 30, 2025 28.70%
Mar 31, 2025 10.67%
Dec 31, 2024 8.47%
Sep 30, 2024 -23.87%
Jun 30, 2024 29.99%
Mar 31, 2024 -12.15%
Dec 31, 2023 -71.84%
Sep 30, 2023 -50.10%
Jun 30, 2023 -74.91%
Mar 31, 2023 -69.28%
Dec 31, 2022 11.26%
Sep 30, 2022 -4.47%
Jun 30, 2022 -18.79%
Mar 31, 2022 -9.63%
Dec 31, 2021 679.28%
Sep 30, 2021 563.08%
Jun 30, 2021 572.81%
Mar 31, 2021 475.58%
Dec 31, 2020 -55.30%
Sep 30, 2020 -52.32%
Jun 30, 2020 -58.75%
Mar 31, 2020 -54.36%
Dec 31, 2019 -22.95%
Sep 30, 2019 13.53%
Jun 30, 2019 20.98%
Mar 31, 2019 14.99%
Dec 31, 2018 137.99%
Sep 30, 2018 144.76%
Jun 30, 2018 263.30%
Mar 31, 2018 148.17%
Dec 31, 2017 10.78%
Sep 30, 2017 46.88%
Jun 30, 2017 -24.91%
Mar 31, 2017 -46.73%
Dec 31, 2016 -59.52%
Sep 30, 2016 -82.33%
Jun 30, 2016 9.44%
Mar 31, 2016 61.00%
Dec 31, 2015 42.52%
Sep 30, 2015 14.63%
Jun 30, 2015 -32.22%
Mar 31, 2015 -39.20%
Dec 31, 2014 46.67%
Sep 30, 2014 102.27%
Jun 30, 2014 -41.79%
Mar 31, 2014 125.03%
Dec 31, 2013 -38.16%
Sep 30, 2013 -60.10%
Jun 30, 2013 323.21%
Mar 31, 2013 55.40%
Dec 31, 2012 555.84%
Sep 30, 2012 374.80%
Jun 30, 2012 -13.47%
Mar 31, 2012 263.23%
Dec 31, 2011 129.36%
Sep 30, 2011 217.34%
Jun 30, 2011 -55.16%